Arvinas announced the appointment of Andrew Saik to the role of CFO and Treasurer reporting to Chairperson, CEO, and President, John Houston, Ph.D. Saik has more than 20 years of biopharma finance experience, most recently serving as CFO at Intercept Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARVN:
- Arvinas announces presentations for two PROTAC investigational programs
- Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
- Arvinas Announces Key Leadership Appointments in R&D
- Arvinas names Ian Taylor as Presdent, R&D, Angela Cacace as CSO
- Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
Questions or Comments about the article? Write to editor@tipranks.com